Greetings from Day 2 of the CHDI HD Therapeutics Conference! HDBuzz continues to provide summaries of the exciting talks from HD scientists gathered in Palm Springs from around the world. This day’s ...
SKY-0515, developed by Skyhawk Therapeutics, is an oral drug taken as a once-daily pill that works by targeting the genetic ...
10 min read | The FDA wants more data before approving AMT-130 for Huntington’s disease in the U.S. On March 2026, uniQure ...
In a press release from February 24th, 2026, Vico Therapeutics have announced that participants are now being dosed in a new fourth arm of their ongoing Phase 1/2a clinical trial of VO659, a drug ...
8 min read | February 2026 HD research recap: published trial data from branaplam trial; new insights into the genetics of the HD “grey zone”; plus worms, brain circuits, eye tracking, and the hidden ...
When caring for people affected by Huntington’s disease (HD), doctors often face major challenges due to the lack of precise tools to track how the disease progresses or to predict exactly when a ...
Your brain is the most advanced supercomputer in the world. But in Huntington’s disease (HD), a core processor of this computer starts to malfunction. Using advanced imaging techniques, a research ...
Imagine walking down your street on a bright, sunny morning when you stumble on the curb. It was only a small trip, nothing serious. You laugh it off and keep walking. But in the back of your mind, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results